HRP20040846A2 - Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents - Google Patents
Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents Download PDFInfo
- Publication number
- HRP20040846A2 HRP20040846A2 HR20040846A HRP20040846A HRP20040846A2 HR P20040846 A2 HRP20040846 A2 HR P20040846A2 HR 20040846 A HR20040846 A HR 20040846A HR P20040846 A HRP20040846 A HR P20040846A HR P20040846 A2 HRP20040846 A2 HR P20040846A2
- Authority
- HR
- Croatia
- Prior art keywords
- migraine
- topiramate
- antimigraine
- treatment
- day
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35989402P | 2002-02-26 | 2002-02-26 | |
| PCT/US2003/005463 WO2003072138A1 (en) | 2002-02-26 | 2003-02-25 | Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20040846A2 true HRP20040846A2 (en) | 2005-06-30 |
Family
ID=27663315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20040846A HRP20040846A2 (en) | 2002-02-26 | 2003-02-25 | Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20030225002A1 (https=) |
| EP (1) | EP1478400A1 (https=) |
| JP (1) | JP2005518439A (https=) |
| KR (1) | KR101008326B1 (https=) |
| CN (1) | CN100352506C (https=) |
| AU (1) | AU2003213242A1 (https=) |
| BR (1) | BR0307951A (https=) |
| CA (1) | CA2419989A1 (https=) |
| HR (1) | HRP20040846A2 (https=) |
| IL (2) | IL163720A0 (https=) |
| MX (1) | MXPA04008259A (https=) |
| NO (1) | NO20043984L (https=) |
| NZ (1) | NZ534874A (https=) |
| PL (1) | PL372393A1 (https=) |
| RU (1) | RU2004126093A (https=) |
| UA (1) | UA81110C2 (https=) |
| WO (1) | WO2003072138A1 (https=) |
| ZA (1) | ZA200407729B (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
| DE10334187A1 (de) * | 2003-07-26 | 2005-03-03 | Schwarz Pharma Ag | Substituierte 2-Aminotetraline zur Behandlung von Depressionen |
| CA2556424A1 (en) | 2004-02-17 | 2005-09-01 | Sepracor Inc. | Treatment or prophylaxis of migraine or headache disorders using citalopram, escitalopram or citalopram metabolites |
| US20060233892A1 (en) * | 2005-04-19 | 2006-10-19 | Curt Hendrix | Topiramate compositions for treatment of headache |
| US20060252745A1 (en) * | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
| FR2890564B1 (fr) * | 2005-09-09 | 2007-10-19 | Servier Lab | Nouvelle association entre l'agomelatine et un inhibiteur de la recapture de la noradrenaline et les compositions pharmaceutiques qui la contiennent |
| EA023147B1 (ru) * | 2006-04-13 | 2016-04-29 | Тева Фармасьютикалс Интернешнл Гмбх | Трансдермальный пластырь для лечения мигрени |
| EP2023894A4 (en) * | 2006-04-25 | 2010-10-20 | Applied Pharma Res | FIXED COMBINATION DOSAGE FOR TREATING MIGRAINE |
| WO2008027557A2 (en) | 2006-08-31 | 2008-03-06 | Spherics, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| SI2124556T1 (sl) | 2006-10-09 | 2015-01-30 | Charleston Laboratories, Inc. | Farmacevtske sestave |
| US8298576B2 (en) | 2006-11-17 | 2012-10-30 | Supernus Pharmaceuticals, Inc. | Sustained-release formulations of topiramate |
| MX2009003911A (es) * | 2006-12-04 | 2009-05-28 | Supernus Pharmaceuticals Inc | Formulaciones de liberacion inmediata, mejoradas de topiramato. |
| GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
| EP3090743A1 (en) | 2008-01-09 | 2016-11-09 | Charleston Laboratories, Inc. | Pharmaceutical compositions for treating headache and eliminating nausea |
| JP5690732B2 (ja) * | 2008-09-17 | 2015-03-25 | ザ マクリーン ホスピタル コーポレーション | 群発頭痛障害を治療するための方法及びキット |
| CA2767576C (en) | 2009-07-08 | 2020-03-10 | Charleston Laboratories Inc. | Pharmaceutical compositions comprising an antiemetic and an opioid analgesic |
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CA3055170A1 (en) | 2016-03-04 | 2017-09-08 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
| WO2018067330A1 (en) * | 2016-10-06 | 2018-04-12 | Baylor College Of Medicine | Photochromatic modulation with fluorescein for the treatment of photo-oculodynia and blepharospasm |
| EP3955933B1 (en) * | 2019-04-15 | 2023-11-29 | Vistagen Therapeutics, Inc. | Treatment of migraine |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| IL103172A (en) * | 1991-09-19 | 1997-01-10 | Mcneilab Inc | Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol |
| US5242942A (en) * | 1992-04-28 | 1993-09-07 | Mcneilab, Inc. | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
| US5998380A (en) * | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
| WO1998007447A1 (en) * | 1996-08-23 | 1998-02-26 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
| US5891885A (en) * | 1996-10-09 | 1999-04-06 | Algos Pharmaceutical Corporation | Method for treating migraine |
| US20020015713A1 (en) * | 1996-10-24 | 2002-02-07 | Murdock Robert W. | Methods and transdermal compositions for pain relief |
| AU1930897A (en) * | 1997-03-03 | 1998-09-22 | Laboratoires Remilea | Plant extract compositions, method of preparation, and pharmaceutical comp ositions containing them |
| US5855907A (en) * | 1997-03-24 | 1999-01-05 | Peyman; Gholam A. | Method of treatment of migraine |
| US5935933A (en) * | 1997-07-16 | 1999-08-10 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in treating neuropathic pain |
| US5760007A (en) * | 1997-07-16 | 1998-06-02 | Ortho Pharmaceutical Corporation | Anticonvulsant derivatives useful in treating neuropathic pain |
| GB9720270D0 (en) * | 1997-09-25 | 1997-11-26 | Pharmagene Lab Limited | Medicaments for the treatment of migraine |
| US6068999A (en) * | 1998-06-25 | 2000-05-30 | Hendrix; Curt | Dietary supplement for supporting cerebrovascular tone and treating migraine headaches |
| ATE279921T1 (de) * | 1999-01-19 | 2004-11-15 | Ortho Mcneil Pharm Inc | Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache |
| PL213323B1 (pl) * | 1999-08-20 | 2013-02-28 | Ortho Mcneil Pharm Inc | Kompozycja farmaceutyczna i jej zastosowanie |
-
2003
- 2003-02-25 RU RU2004126093/14A patent/RU2004126093A/ru not_active Application Discontinuation
- 2003-02-25 UA UA20040807114A patent/UA81110C2/uk unknown
- 2003-02-25 CN CNB038091135A patent/CN100352506C/zh not_active Expired - Lifetime
- 2003-02-25 IL IL16372003A patent/IL163720A0/xx unknown
- 2003-02-25 HR HR20040846A patent/HRP20040846A2/hr not_active Application Discontinuation
- 2003-02-25 US US10/373,488 patent/US20030225002A1/en not_active Abandoned
- 2003-02-25 NZ NZ534874A patent/NZ534874A/en not_active IP Right Cessation
- 2003-02-25 KR KR1020047013261A patent/KR101008326B1/ko not_active Expired - Fee Related
- 2003-02-25 BR BR0307951-1A patent/BR0307951A/pt not_active Application Discontinuation
- 2003-02-25 MX MXPA04008259A patent/MXPA04008259A/es unknown
- 2003-02-25 WO PCT/US2003/005463 patent/WO2003072138A1/en not_active Ceased
- 2003-02-25 JP JP2003570882A patent/JP2005518439A/ja active Pending
- 2003-02-25 PL PL03372393A patent/PL372393A1/xx not_active Application Discontinuation
- 2003-02-25 AU AU2003213242A patent/AU2003213242A1/en not_active Abandoned
- 2003-02-25 EP EP03709289A patent/EP1478400A1/en not_active Withdrawn
- 2003-02-26 CA CA002419989A patent/CA2419989A1/en not_active Abandoned
-
2004
- 2004-08-24 IL IL163720A patent/IL163720A/en active IP Right Grant
- 2004-09-23 ZA ZA200407729A patent/ZA200407729B/en unknown
- 2004-09-23 NO NO20043984A patent/NO20043984L/no unknown
-
2006
- 2006-12-08 US US11/608,276 patent/US20070099849A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1478400A1 (en) | 2004-11-24 |
| PL372393A1 (en) | 2005-07-25 |
| JP2005518439A (ja) | 2005-06-23 |
| CN100352506C (zh) | 2007-12-05 |
| IL163720A (en) | 2012-06-28 |
| NZ534874A (en) | 2007-03-30 |
| NO20043984L (no) | 2004-09-23 |
| KR20040091074A (ko) | 2004-10-27 |
| MXPA04008259A (es) | 2005-05-27 |
| US20030225002A1 (en) | 2003-12-04 |
| UA81110C2 (en) | 2007-12-10 |
| BR0307951A (pt) | 2004-12-21 |
| ZA200407729B (en) | 2006-06-28 |
| IL163720A0 (en) | 2005-12-18 |
| CA2419989A1 (en) | 2003-08-05 |
| AU2003213242A1 (en) | 2003-09-09 |
| RU2004126093A (ru) | 2005-04-10 |
| CN1646168A (zh) | 2005-07-27 |
| US20070099849A1 (en) | 2007-05-03 |
| KR101008326B1 (ko) | 2011-01-13 |
| WO2003072138A1 (en) | 2003-09-04 |
| HK1080731A1 (en) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20040846A2 (en) | Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents | |
| Klein et al. | Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? | |
| EP3687576B1 (en) | Use of cannabidiol in combination with norfenfluramine or fenfluramine in the treatment of epilepsy | |
| Vinik et al. | Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies | |
| CA2580619C (en) | Use of memantine (namenda) to treat autism, compulsivity, and impulsivity | |
| US6627653B2 (en) | Anticonvulsant derivatives useful for the treatment of depression | |
| EP3340971B1 (en) | Methods of treating lennox-gastaut syndrome using fenfluramine | |
| US11571397B2 (en) | Compositions and methods for treating seizure-induced sudden death | |
| CA3062247A1 (en) | Methods of treating doose syndrome using fenfluramine | |
| CA2459146A1 (en) | Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors | |
| JP2004527553A (ja) | 抗痙攣性誘導体と非典型的抗精神病薬を用いた共治療を含んで成る精神病性障害治療 | |
| Latini et al. | Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy | |
| Pabis et al. | Pharmacotherapy of aggressive behavior | |
| KR20220101610A (ko) | 펜플루라민을 사용하여 간질 환자를 치료하는 방법 | |
| Tracz et al. | Epilepsy and Related Seizure Disorders | |
| HK1080731B (en) | Use of a combination of anticonvulsant derivatives and anti-migraine agents in manufacture of medicaments | |
| AU2011235981B2 (en) | Use of Memantine (Namenda) to Treat Autism, Compulsivity, and Impulsivity | |
| CA3233107A1 (en) | 2-fluorodeschloroketamine for treatment of depression, including treatment-resistant depression | |
| EA044821B1 (ru) | Способ увеличения биологической доступности и степени воздействия активатора потенциал-зависимых калиевых каналов | |
| Jedsadayanmata | Zonisamide: Clinical efficacy and safety in refractory partial epilepsy | |
| Wang et al. | Drugs Commonly Used to Treat Refractory Status Epilepticus in Clinical Practice | |
| HK1255881A1 (zh) | 使用芬氟拉明治疗lennox-gastaut综合征的方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20130104 Year of fee payment: 11 |
|
| ODBI | Application refused |